SEMA3A co-cultured with purified B cells from SLE patients significantly reduced TLR-9 expression, supporting the idea that SEMA3A may regulate B-cell autoimmunity in SLE [66]. This evidence concerns the gene TLR9 and systemic lupus erythematosus.